Prosecution Insights
Last updated: August 17, 2026

Examiner: PURDY, KYLE A

Tech Center 1600 • Art Units: 1611

This examiner grants 41% of resolved cases

Performance Statistics

41.0%
Allow Rate
-19.0% vs TC avg
1,060
Total Applications
+36.5%
Interview Lift
1521
Avg Prosecution Days
Based on 992 resolved cases, 2023–2026

Rejection Statute Breakdown

1.4%
§101 Eligibility
13.7%
§102 Novelty
63.0%
§103 Obviousness
14.3%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18667002 SKIN CARE SERUM COMPOSITION WITH NATURAL POLYMERS Final Rejection The Procter & Gamble Company
17422859 ANTIBACTERIAL COMPOSITION Non-Final OA LG CHEM, LTD.
18043142 COMBINATION THERAPY OF A RAF INHIBITOR AND A MEK INHIBITOR FOR THE TREATMENT OF SARCOMA Final Rejection Board of Regents, The University of Texas System
18256655 EXTRACT OF AT LEAST ONE PLANT OF THE CROCUS SATIVUS SPECIES COMPRISING A HIGH CONTENT OF CROCINS AND A LOW CONTENT OF SAFRANAL, AND COSMETIC USE THEREOF AS ANTIOXIDANT Final Rejection L'OREAL
17273857 METHOD OF PRODUCING METAL NANOPARTICLES AND USES THEREOF Non-Final OA RAMOT AT TEL-AVIV UNIVERSITY LTD.
17609299 COMPOSITION FOR PREVENTING OR TREATING INFLAMMATION, ALLERGIES AND ASTHMA, CONTAINING VERONICASTRUM SIBIRICUM L. PENNELL AS ACTIVE INGREDIENT, AND USE THEREOF Final Rejection KT&G CORPORATION

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month